Nexalin Technology (NXL) Operating Margin (2021 - 2026)
Nexalin Technology's quarterly Operating Margin came in at 14179.95% in Q1 2026, down 927631.0% year-on-year from N/an in Q1 2025, and down 910.07% quarter-over-quarter from 1403.86% in Q4 2025.
Nexalin Technology has reported Operating Margin for 6 years, with the latest figure at 14179.95% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin fell 927631.0% year-over-year to 14179.95%; the trailing twelve-month figure through Mar 2026 stood at 3084.22% (up 354772.0% YoY), and the FY2025 full-year result was 2781.69%, up 181445.0% from the prior year.
- Operating Margin for Q1 2026 stood at 14179.95%, down from 1403.86% in the prior quarter.
- The five-year high for Operating Margin was 53.77% in Q3 2022, with the low at 14179.95% in Q1 2026.
- Average Operating Margin over 5 years is 4973.09%, with a median of 2550.48% recorded in 2023.
- Year-over-year, Operating Margin plunged 996381 bps in 2023 and soared 917562 bps in 2025.
- Tracing NXL's Operating Margin over 5 years: stood at 1872.83% in 2022, then tumbled by 322 bps to 7910.37% in 2023, then sank by 34 bps to 10579.48% in 2024, then surged by 87 bps to 1403.86% in 2025, then plunged by 910 bps to 14179.95% in 2026.
- The last three Operating Margin figures came in at 14179.95% (Q1 2026), 1403.86% (Q4 2025), and 12924.3% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Nexalin Technology | 11.19 Mn | 8.48 Mn | 13,133.00 | -14,179.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14,179.95% |
| Dec 31, 2025 | -1,403.86% |
| Sep 30, 2025 | -12,924.30% |
| Jun 30, 2025 | -2,296.22% |
| Mar 31, 2025 | -4,903.63% |
| Dec 31, 2024 | -10,579.48% |
| Sep 30, 2024 | -6,962.11% |
| Jun 30, 2024 | -4,832.42% |
| Mar 31, 2024 | -1,364.81% |
| Dec 31, 2023 | -7,910.37% |
| Sep 30, 2023 | -10,017.57% |
| Jun 30, 2023 | -2,467.25% |
| Mar 31, 2023 | -2,550.48% |
| Dec 31, 2022 | -1,872.83% |
| Sep 30, 2022 | -53.77% |
| Jun 30, 2022 | -107.44% |
| Mar 31, 2022 | -116.02% |
| Dec 31, 2021 | -2,406.30% |
| Sep 30, 2021 | -3,207.88% |